[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB0105893D0 - Pharmaceutically active compounds - Google Patents

Pharmaceutically active compounds

Info

Publication number
GB0105893D0
GB0105893D0 GBGB0105893.2A GB0105893A GB0105893D0 GB 0105893 D0 GB0105893 D0 GB 0105893D0 GB 0105893 A GB0105893 A GB 0105893A GB 0105893 D0 GB0105893 D0 GB 0105893D0
Authority
GB
United Kingdom
Prior art keywords
active compounds
pharmaceutically active
pharmaceutically
compounds
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0105893.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GBGB0105893.2A priority Critical patent/GB0105893D0/en
Publication of GB0105893D0 publication Critical patent/GB0105893D0/en
Priority to PCT/IB2002/000622 priority patent/WO2002072586A1/en
Priority to US10/092,992 priority patent/US20020173502A1/en
Priority to GT200200044A priority patent/GT200200044A/en
Priority to PE2002000183A priority patent/PE20021153A1/en
Priority to APAP/P/2002/002462A priority patent/AP2002002462A0/en
Priority to HN2002000050A priority patent/HN2002000050A/en
Priority to TNTNSN02023A priority patent/TNSN02023A1/en
Priority to PA20028541101A priority patent/PA8541101A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0105893.2A 2001-03-09 2001-03-09 Pharmaceutically active compounds Ceased GB0105893D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0105893.2A GB0105893D0 (en) 2001-03-09 2001-03-09 Pharmaceutically active compounds
PCT/IB2002/000622 WO2002072586A1 (en) 2001-03-09 2002-02-27 Pyrazolo'4,3-d-pyrimidine for inhibiting cgmp pde
US10/092,992 US20020173502A1 (en) 2001-03-09 2002-03-06 Pharmaceutically active compounds
GT200200044A GT200200044A (en) 2001-03-09 2002-03-06 PHARMACEUTICALLY ACTIVE COMPOUNDS
PE2002000183A PE20021153A1 (en) 2001-03-09 2002-03-07 5- [2-BUTOXY-5- (1-HYDROXYETHYL) -3-PYRIDINYL] -3-ETHYL-2- (1-ETHYL-3-AZETHYDINYL) -2,6-DIHYDRO-7H-PYRAZOLE [4,3- d] PYRIMIDIN-7-ONA AS INHIBITORS OF GUANOSIN 3 ', 5'-CYCLIC MONOPHOSPHATE PHOSPHODIESTERASES
APAP/P/2002/002462A AP2002002462A0 (en) 2001-03-09 2002-03-07 Pharmaceutically active compounds.
HN2002000050A HN2002000050A (en) 2001-03-09 2002-03-08 PHARMACEUTICALLY ACTIVE COMPOUNDS
TNTNSN02023A TNSN02023A1 (en) 2001-03-09 2002-03-08 PYRAZOLOPYRIMIDINE DERIVATIVES NOVEL cGMP-PDE INHIBITORS AND COMPOSITIONS CONTAINING THEM.
PA20028541101A PA8541101A1 (en) 2001-03-09 2002-03-08 PHARMACEUTICALLY ACTIVE COMPOUNDS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0105893.2A GB0105893D0 (en) 2001-03-09 2001-03-09 Pharmaceutically active compounds

Publications (1)

Publication Number Publication Date
GB0105893D0 true GB0105893D0 (en) 2001-04-25

Family

ID=9910362

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0105893.2A Ceased GB0105893D0 (en) 2001-03-09 2001-03-09 Pharmaceutically active compounds

Country Status (8)

Country Link
AP (1) AP2002002462A0 (en)
GB (1) GB0105893D0 (en)
GT (1) GT200200044A (en)
HN (1) HN2002000050A (en)
PA (1) PA8541101A1 (en)
PE (1) PE20021153A1 (en)
TN (1) TNSN02023A1 (en)
WO (1) WO2002072586A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
KR20070091049A (en) 2002-12-13 2007-09-06 워너-램버트 캄파니 엘엘씨 Alpha-2-delta ligand to treat lower urinary tract symptoms
MXPA06000623A (en) * 2003-07-16 2006-04-11 Pfizer Treatment of sexual dysfunction.
JP2009503020A (en) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Use of flibanserin in the treatment of obesity
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
JP2009541443A (en) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Flibanserin for the treatment of urinary incontinence and related diseases
AU2007286288A1 (en) 2006-08-14 2008-02-21 Boehringer Ingelheim International Gmbh Formulations of flibanserin and method for manufacturing the same
BRPI0716436B8 (en) 2006-08-25 2021-05-25 Boehringer Ingelheim Int controlled release system and method for manufacturing it
CL2008002693A1 (en) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE247117T1 (en) * 1998-04-20 2003-08-15 Pfizer PYRAZOLOPYRIMIDINONE CGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL FUNCTION DISORDERS
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
PL357522A1 (en) * 1999-10-11 2004-07-26 Pfizer, Inc. 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors
CO5271697A1 (en) * 2000-01-12 2003-04-30 Pfizer Prod Inc COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF AFFECTIONS THAT RESPOND TO AN INCREASE OF TESTOSTERONE

Also Published As

Publication number Publication date
PA8541101A1 (en) 2003-11-12
TNSN02023A1 (en) 2005-12-23
AP2002002462A0 (en) 2002-06-30
HN2002000050A (en) 2002-09-13
GT200200044A (en) 2002-12-02
PE20021153A1 (en) 2002-12-17
WO2002072586A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
EG24411A (en) Pharmaceutically active compounds
GB9924020D0 (en) Pharmaceutically active compounds
IL146117A0 (en) New pharmaceutically active compounds
HUP0400732A3 (en) Pharmaceutically active uridine esters
GB0101227D0 (en) Pharmaceutical compounds
GB0101225D0 (en) Pharmaceutical compounds
GB0105893D0 (en) Pharmaceutically active compounds
GB0107751D0 (en) Pharmaceutically active compounds
GB0106631D0 (en) Pharmaceutically active compounds
GB0112561D0 (en) Active plate
GB0017822D0 (en) Pharmaceutically active compound
GB0112563D0 (en) Active plate
GB0219897D0 (en) Pharmaceutically active compounds
GB0106629D0 (en) Pharmaceutically active compounds
GB0106617D0 (en) Pharmaceutically active compounds
GB0106651D0 (en) Pharmaceutically active compounds
GB0106561D0 (en) Pharmaceutically active compounds
GB0106562D0 (en) Pharmaceutically active compounds
GB0219893D0 (en) Pharmaceutically active compounds
GB0018656D0 (en) Pharmaceutically active compounds
GB0007345D0 (en) Pharmaceutically active compounds
GB0018660D0 (en) Pharmaceutically active compounds
GB9926630D0 (en) Pharmacologically active compounds
GB0219895D0 (en) Pharmaceutically active compounds
GB0105766D0 (en) Orally active compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)